Clonal diversity of clinical isolates producing NDM-type carbapenemase in Cuba, 2013-19.

Objectives: Our study aimed to elucidate the clonal diversity of carbapenem-resistant clinical isolates producing NDM-type carbapenemase collected through national surveillance in Cuba during a 7-year period (2013-19).

Methods: A total of 199 isolates of spp. from 37 hospitals in 12 provinces were genetically analyzed for their species, carbapenemase genes and genotypes.

Community-Acquired Uropathogenic , Antimicrobial Susceptibility, and Extended-Spectrum Beta-Lactamase Detection.

Introduction: Urinary tract infection is the second-leading reason for consults in primary health care. Bacterial urinary tract infections are the most common, of which is the main etiologic agent. Antimicrobial resistance and multidrug resistance complicate effective community treatment, especially if resistance is caused by extended-spectrum beta-lactamase production.

Multicenter Study of Carbapenemase-Producing in Havana, Cuba, 2016-2021.

Surveillance of carbapenem resistance is particularly important for mainly in countries with limited healthcare resources. We conducted a cross-sectional study to detect carbapenem-resistant at 10 sentinel hospitals in Havana, Cuba for a six year-period (2016-2021) by the National Reference Laboratory for Health Care-Associated Infections in the Pedro Kourí Institute. A total of 152 isolates were collected with phenotypic production of metallo-β-lactamase.

Carbapenamase-Producing Acinetobacter baumannii in China, Latin America and the Caribbean.

Introduction: Carbapenem-resistant Acinetobacter baumannii is a complex health problem, causing difficulties in clinical-therapeutic management worldwide. It is of particular concern in Latin America, the Caribbean and China, where it is an emerging health problem. Carbapenemases produced by these organisms inactivate carbapenem antibiotics.